Evidence map›Paper›PMID 41529089›Full record

ArticleJMIR cancer2026

New Technologies and Digital Health Tools in Patients With Solid Tumors and Hematological Malignancies: Cross-Sectional Multicenter Survey Study.

Alberto Lopez-Garcia, Carola Diaz-Aizpun, Beatriz Gallego-Diaz, Carolina Miranda-Castillo, Maria Yuste-Platero, Pilar Beltran-Alvarez, Cristina Carames-Sanchez, Jesus Garcia-Foncillas, Pilar Llamas-Sillero, Marta Del Olmo-Rodriguez and 4 more

Abstract readMulticenter Study
In one paragraph

Article in JMIR cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alberto Lopez-Garcia *Lymphoma Unit, Department of Hematology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0000-0002-5354-5261
Carola Diaz-Aizpun *Department of Hematology, Regional University Hospital, Malaga, Spain.ORCID 0000-0003-0446-8172
Beatriz Gallego-DiazLymphoma Unit, Department of Hematology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0009-0006-1840-1402
Carolina Miranda-CastilloDepartment of Hematology, Rey Juan Carlos University Hospital, Madrid, Spain.ORCID 0000-0001-8763-9576
Maria Yuste-PlateroDepartment of Hematology, Villalba General University Hospital, Madrid, Spain.ORCID 0000-0002-8673-2012
Pilar Beltran-AlvarezDepartment of Hematology, Infanta Elena University Hospital, Madrid, Spain.ORCID 0009-0003-3332-7165
Cristina Carames-SanchezDepartment of Oncology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0000-0002-5748-7628
Jesus Garcia-FoncillasDepartment of Oncology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0000-0002-7591-8006
Pilar Llamas-SilleroDepartment of Hematology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0000-0002-8552-3219
Marta Del Olmo-RodriguezClinical and Organizational Research Unit, Quironsalud Hospital, Avenida Reyes Católicos 2, Madrid, 28040, Spain, 34 900301013.ORCID 0009-0008-6876-1355
Jorge Short-ApellanizClinical and Organizational Research Unit, Quironsalud Hospital, Avenida Reyes Católicos 2, Madrid, 28040, Spain, 34 900301013.ORCID 0000-0002-5865-5355
Bernadette PfangClinical and Organizational Research Unit, Quironsalud Hospital, Avenida Reyes Católicos 2, Madrid, 28040, Spain, 34 900301013.ORCID 0000-0002-0317-2778
Javier Arcos-CampilloClinical and Organizational Research Unit, Quironsalud Hospital, Avenida Reyes Católicos 2, Madrid, 28040, Spain, 34 900301013.ORCID 0000-0002-5621-7116
Raul CordobaLymphoma Unit, Department of Hematology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0000-0002-7654-8836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Barriers to eHealth use include lack of technological infrastructure, resistance to change, and inequities in access. However, patterns of access to and use of eHealth tools in people being treated for cancer have not been fully described in the literature. Objective: Our aim was to describe the patterns of access to and use of eHealth tools among outpatients receiving treatment for hematological malignancies and solid tumors. Methods: We conducted a cross-sectional multicenter study using a survey offered to patients aged over 18 years receiving outpatient treatment for hematological malignancies or solid tumors at 4 teaching hospitals in Madrid, Spain, between February 1, 2021, and November 30, 2021. The survey instrument featured questions about patients' demographic and social characteristics, cancer diagnosis, use of information and communication technology (ICT), use and opinions of the Patient Portal, and changes in ICT use during the COVID-19 pandemic. To study the relationship between the different variables, 2-tailed Student t tests or ANOVA were used for variables with normal distribution, and the Mann-Whitney or Kruskal-Wallis tests were used for variables with nonnormal distribution. Statistical analyses were performed using SPSS (version 25; IBM Corp) for Windows. Results: In total, 200 patients were included in our study. Median age was 60 (range 21-87) years. A total of 130 (65%) patients presented with hematological malignancies. Most (n=181, 90.5%) patients considered that eHealth tools might help to improve communication with the medical team during their treatment. Retired participants (28.6% vs 71.4%; P<.001), those older than 60 years (26% vs 74%; P<.001), and those without higher education (2.6% vs 97.4%; P<.001) showed significantly lower rates of internet use, with no observed sex-related differences. A total of 177 (88.5%) patients found the Patient Portal useful, and 140 (70%) reported increased use of ICT due to the COVID-19 pandemic. Conclusions: Most (177/200, 88.5%) patients viewed eHealth tools as useful and believed that it was helpful to improve communication with their care team. However, notable gaps in the use of eHealth were observed in certain groups of patients, with significant differences in use due to age, education, and employment status. Strategies to identify subgroups at risk for unequal access to digital health, as well as to facilitate access and use, are warranted.

Indexed as

COVID-19Hematologic NeoplasmsNeoplasmsTelemedicineAdultAgedAged, 80 and overCross-Sectional StudiesDigital HealthFemaleHumansMaleMiddle AgedPatient PortalsSARS-CoV-2Spainbarriercancercancer carecancer diagnosiscross-sectional studydigital health toolseHealthhematological malignanciesoncohematologysurveytelemedicinetumor

Identifiers

PMID41529089
PMCPMC12798843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.